Linagliptin 5mg

Olinpa contains Linagliptin which belongs to a class of anti-hyperglycemic agents called Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and it is used to reduce blood glucose levels in adults with type 2 diabetes T2D.

• Convenient once-daily dosing.
• Clinically significant glycemic efficacy in lowering HbA1C.
• Safe for T2D patients with high cardiovascular disease (CVD) risk. First DPP-4 inhibitor with a nonrenal elimination route.
• Safe for patients with renal impairment without dose adjustment or monitoring of renal function.
• Low potential for drug-drug interactions.
• Low risk of hypoglycemia.
• Weight neutral.
• Safe and well tolerated.